Connection
Co-Authors
This is a "connection" page, showing publications co-authored by David Camidge and Breelyn Wilky.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.301 |
|
|
|
-
Chaudhry SS, Camidge DR, Clay MR, Wilky BA. Durable response with mutation-guided ALK inhibition in a patient with metastatic epithelioid inflammatory myofibroblastic sarcoma: A case report. Rare Tumors. 2025; 17:20363613251392655.
Score: 0.242
-
Alsafar A, Kareem SL, Corr BR, Lieu CH, Wilky B, Davis SL, Camidge DR, Jimeno A, Messersmith WA, Nicklawsky A, Pacheco D, Borrayo EA, McDermott JD, Diamond JR. Increased accrual of diverse patient populations in oncology phase I clinical trials at the University of Colorado Cancer Center. Front Oncol. 2025; 15:1546500.
Score: 0.059